A patient returns to your clinic seeking systemic therapy for her AD while postpartum and breastfeeding. Test your knowledge on injectables.
A panelist discusses how the advent of targeted systemic therapies such as dupilumab and nemolizumab has transformed the treatment landscape for prurigo nodularis, offering more effective options for breaking the itch-scratch cycle while maintaining favorable safety profiles compared with traditional systemic treatments.
Doctors cite more support staff, reduced patient panels among solutions.
Metz and Tollefson share insights on efficient practice management, work-life balance, and exciting developments in pediatric dermatology.
Along with this new transparency regarding treatments, patients are empowered to embrace more comprehensive beauty ideals.
AI’s ability to quickly process and interpret large quantities of health data is a valuable tool for physicians.
In most kidney transplant recipients with advanced skin cancer, 2 checkpoint inhibitors are needed to boost the immune system, according to a new study.
Dermatologists Jeanine Downie, DiAnne Davis, and Hope Mitchell reveal the La Roche-Posay products they recommend to patients with dry skin, eczema, and more, at the flagship store in France.
Daniel Siegel, MD, shared strategies to manage surgery challenges, especially bleeding, to ensure a smooth experience for patients.
Survey responses revealed the rates and times at which patients switched from oral to biologic therapies.
Findings from a retrospective cohort study found that immune checkpoint inhibitors induced promising responses in the first- and second-line treatment of head and neck squamous cell carcinoma.
Expert insights on the latest issues in wounds as well as HS resources are shared at the annual meeting.
Jeffrey Yager, MD, discusses the new SY Aesthetics campus that will integrate traditional and Chinese healing.
In part 4 of this Frontline Forum series, John M. Strasswimmer, MD, PhD; Andrew H. Weinstein, MD; Neal Bhatia, MD; Laura Ferris, MD; and Aaron S. Farberg, MD, discuss solutions for managing and treating patients with basal cell carcinoma.
In this study, the highest infertility rate was seen in the patients living with hidradenitis suppurativa; however, no direct causality was seen for this, with the authors noting diseases and symptoms comprised the only factors with a statistically significant relationship to infertility.
Hidradenitis suppurativa requires clinical vigilance, empathy, and the courage to escalate therapy early.
Peter Lio, MD, reflects on current unmet needs in atopic dermatitis and suggests directions for future research and development.
López-Ferrer discussed how to achieve well-being for patients with psoriasis and Koscielny discussed the unique topics of the Skin Academy.
Experts discuss the treatment landscape of generalized pustular psoriasis as well as review difficult cases of GPP.
Jerry Brewer, MD, MS, shared pearls on reasons to avoid or discontinue Mohs surgery and keeping calm with stressed, vulnerable patients.
Arash Mostaghimi, MD, MPH, MPA, provides insights into what clinicians need to know about deuruxolitinib for severe AA.
The poster, which shares results form consensus research on using LODM for hair loss, was awarded 4th place at the 2024 AAD Annual Meeting.
By integrating capabilities and services, we can create health experiences that are much more than the sum of their parts.
The investigator in the clinical development program for deuruxolitinib shared data, patient populations to consider, and more in a recent interview.
A 5-month-old girl with a large scalp infantile hemangioma (IH), present since 6 weeks of age, is evaluated in the emergency department for lethargy and pallor.